Late subsequent Merkel cell carcinoma after 21 years of the first primary diagnosis: When to de‐escalate surveillance?

Merkel cell carcinoma (MCC) presents challenges in surveillance due to varied recurrence rates and uncertain follow-up protocols, especially in late recurrent cases. These cases need personalized monitoring strategies beyond traditional timelines, such as clinical and molecular factors, in order to optimize patient outcomes.